Categories
Health

Ei-ichi Negishi, Nobel Prize Winner in Chemistry, Dies at 85

Ei-ichi Negishi, who shared the Nobel Prize in Chemistry in 2010 for developing techniques now ubiquitous in the manufacture of pharmaceuticals, died on June 6 in Indianapolis. He was 85.

His death, at a hospital, was announced by Purdue University, where Dr. Negishi was a professor for four decades. No cause was given.

Dr. Negishi’s Nobel-winning research involved chemical reactions that produce complex organic compounds — large carbon-based molecules used in drugs, plastics and many other industrial materials. Coaxing one carbon atom to bond to another can be difficult, but Dr. Negishi and other chemists figured out that metals, palladium in particular, could be used as intermediary matchmakers.

In these reactions, two carbon-based molecules first stick to the palladium. The palladium then disconnects from them, and the two carbons attach to each other, forming a new, larger molecule. With the palladium working as a catalyst, the organic chemistry reactions can run at lower temperatures with fewer steps, reducing cost and waste.

“It just allows this enormous selectivity,” said James M. Tour, a professor of chemistry at Rice University in Houston, who was a graduate student of Dr. Negishi’s. “When you build molecules, you have to be able to work on one part of the molecule without destroying the other part.”

Chemists had discovered the magic of palladium earlier, and in 1977 Dr. Negishi built on that work by using zinc compounds to ease the mingling of carbon atoms on palladium. That made the process more applicable to a wider range of reactions.

“Without organic compounds, none of us can live,” Dr. Negishi said in a news conference on the day the Nobel was announced. “One of our major dream goals is to be able to synthesize any organic compounds in high yield, high efficiency.”

He gave as an analogy the creating of elaborate Lego formations. “That is a pretty accurate description of what we have been trying to do,” he said.

Traditionally, organic chemists largely limited themselves to molecules using the 10 or so elements found in organic compounds. Dr. Negishi said that he and others had “realized that we should make use of the entire periodic table.”

By expanding to other elements like palladium, chemists in effect increased the number of Lego pieces they could use, and that opened new avenues to synthesize the molecules they wanted to make.

Dr. Negishi shared the 2010 Nobel in Chemistry with Richard F. Heck of the University of Delaware and Akira Suzuki of Hokkaido University in Sapporo, Japan.

Unlike many Nobelists who say they never expected to receive the highest honor in the science world, Dr. Negishi said it was “not a major surprise” to receive an early morning phone call on Oct. 6, 2010, from the Royal Swedish Academy of Sciences, which administers the Nobels.

Dr. Tour said Dr. Negishi had pursued research that he thought was Nobel-worthy. “He dreamed about it,” Dr. Tour said. “He often discussed the Nobel Prize. And what would have to be done to win this.”

To that end, Dr. Negishi could be relentless. “He was extremely exacting,” Dr. Tour said. “He had no trouble pushing people to the point of tears at a blackboard.”

Dr. Tour said Dr. Negishi also had a generous side. “If anybody would walk up to his office door and knock, his door was always open,” Dr. Tour said. “And you’d usually sit down for much longer than you bargained for, because he analyzed the whole project you’re working on, not just the question that you’re asking.”

Ei-ichi Negishi was born on July 14, 1935, in Changchun, China, then known as Hsinking, the capital of the Japanese-controlled part of the country, in the northeast. His family moved to Tokyo after World War II and then to a rural area outside Tokyo, where his father farmed and his mother took care of the family’s five children.

After graduating from the University of Tokyo in 1958 with a bachelor of engineering degree, he worked as a research chemist at the Iwakuni Research Laboratories in Japan. By his account, he realized that he needed more academic training but felt that graduate school was financially out of reach.

His fortunes changed in 1960, however, when he won a Fulbright scholarship to attend the University of Pennsylvania. After finishing his doctorate in 1963, he joined the laboratory of Herbert C. Brown at Purdue. Dr. Brown became the first Purdue faculty member to win a Nobel Prize, in 1979; Dr. Negishi was the second.

“In terms of research, he is my only mentor,” Dr. Negishi said of Dr. Brown in an interview after the Nobel announcement. “I have had other professors, but he taught me just about everything as to how to do research.”

Dr. Negishi moved to Syracuse University as an assistant professor in 1972 and returned to Purdue in 1979 as a professor. He retired in 2019, having been an author of more than 400 scientific papers.

In 2010, Dr. Negishi, who remained a Japanese citizen, received the Order of Culture from Emperor Akihito. He was elected to the National Academy of Sciences in 2014.

Survivors include two daughters, four grandchildren and one great-granddaughter. His wife of 58 years, Sumire, died in 2018.

“When he got his Nobel Prize, he became nicer,” Dr. Tour said. “He’d take his wallet out of his pocket, and protruding from his wallet was the Nobel Prize medallion.”

Dr. Tour said Dr. Negishi would pass the medal around and didn’t mind when someone once dropped it. “You could see the ding in one side of it,” Dr. Tour said. “And he just laughed about it.”

Categories
Health

You Can Bid on NFTs Tied to Nobel Prize-Profitable Discoveries

How much will someone be willing to pay for a few pages of quarter-century-old bureaucratic university paperwork that have been turned into a blockchain-encoded piece of digital art?

The University of California, Berkeley, hopes quite a bit, and it is about to find out.

Berkeley announced on Thursday that it will auction the first of two digital art pieces known as nonfungible tokens, or NFTs, next week. The object being offered is based on a document called an invention and technology disclosure. That’s the form that researchers at Berkeley fill out to alert the university about discoveries that have potential to be turned into lucrative patents.

The title of the invention, from 1996, is “Blockade of T-Lymphocyte Down-Regulation Associated with CTLA-4 Signalling.”

The university hopes that potential bidders will be attracted to an early description of a revolutionary approach to treating cancer developed by James P. Allison, then a professor at Berkeley. He found a way to turn off the immune system’s aversion to attacking tumors and he showed that it worked in mice.

That advance eventually led to the creation of Yervoy, a drug for the treatment of metastatic melanoma, and Dr. Allison, who is now at the MD Anderson Cancer Center at the University of Texas, shared the Nobel Prize in Medicine in 2018.

Thus, the Berkeley disclosure form could be thought of as the scientific equivalent of Mickey Mantle’s rookie baseball card — a memento of the beginnings of greatness.

“I think of it almost as a history of science artifact,” said Richard K. Lyons, the chief innovation and entrepreneurship officer at Berkeley. “Imagine somebody saying, ‘I want to own the NFTs for the 10 most important scientific discoveries of my lifetime.’”

A 24-hour auction of the NFT of Dr. Allison’s invention disclosure will take place as early as June 2 using Foundation, an NFT auction marketplace that uses Ethereum, the cryptocurrency network of choice for NFT collectors.

Eighty-five percent of the proceeds will go to Berkeley to finance research, the remainder to Foundation. If the piece is later resold, Berkeley will receive 10 percent of the sale and Foundation 5 percent.

Because the making of an NFT requires a lot of computing power, part of the money the university earns from the NFT sale will be used for carbon offsets to compensate for the energy consumed, Berkeley officials said.

The second NFT that Berkeley plans to auction in the coming weeks will be the disclosure form describing the CRISPR-Cas9 gene editing invention by Jennifer A. Doudna, a professor of molecular and cell biology at Berkeley. She shared the 2020 Nobel Prize in Chemistry with Emmanuelle Charpentier of the Max Planck Unit for the Science of Pathogens for their work on the technique.

NFTs have become trendy collectibles in recent months. A unique code embedded in a digital image or video serves as a record of its authenticity and is stored on a blockchain, the same technology that underlies digital currencies like Bitcoin. NFTs can then be bought and sold, just like baseball cards, and the blockchain ensures they cannot be deleted or counterfeited.

A dizzying array of documents, far beyond traditional works of art, have been sold as NFTs. Jack Dorsey, the founder of Twitter, sold an NFT of his first tweet for $2.9 million. Kevin Roose, a New York Times columnist, sold an NFT of his article about NFTs for more than half a million dollars. (The money went to The Times’s Neediest Cases Fund.)

The pages of Dr. Allison’s disclosure form, drawn from the Berkeley archives, make for mostly dry reading. There is a July 11, 1995, letter from Carol Mimura, a licensing associate at Berkeley, thanking Dr. Allison for contacting the university’s office of technology licensing and asking him to fill out some forms. Another page includes Berkeley’s patent policy.

The documents reflect quaintly archaic technologies used in the mid-1990s — typewriters, fax machines and handwritten notes. “I am scrambling to protect patentable matter before late July,” reads a memo from Dr. Mimura, now the assistant vice chancellor for intellectual property and industry research alliances.

A fax from Dr. Allison to Dr. Mimura includes a simple chart with three lines and 21 data points. “Carol — This is the data that has got us excited,” Dr. Allison has scribbled.

His research group was experimenting with colon cancer in mice, and blocking CTLA-4 — a protein receptor that acts as an on-off switch for the immune system — “led to the rejection of the tumor in 5/5 mice,” Dr. Allison wrote.

Until now, these forms, filed away, unseen, have had no value, Dr. Allison concedes.

“That very first exposure to the world is sort of like, ‘This is the invention disclosure,’” he said. “But once they’ve served that purpose, historically, they get no attention.”

The NFT idea was the brainchild of Michael Alvarez Cohen, director of innovation ecosystem development in Berkeley’s intellectual property office. He said part of the idea came after the publication of “The Code Breaker” by Walter Isaacson, a biography of Dr. Doudna. His friends and relatives told him that they had not known that much of the gene editing technology had originated at Berkeley.

“So I was kind of like, ‘Maybe we should post excerpts from the invention disclosure to help promote this,’” he said.

At the same time, he was following news about blockchain and NFTs.

“Then about a month ago, I put the two together,” Mr. Cohen said. Take the invention disclosures about Nobel-winning research like CRISPR, turn them into NFTs, “and drive awareness and also fund research by auctioning the NFTs.”

He sat on the idea for a while.

“I come up with a lot of ideas,” Mr. Cohen said. “Some of them are bone-headed and everything.”

Just over two weeks ago, he started discussing it with his colleagues, and quickly a plan fell into place. In addition to CRISPR, they decided to highlight Dr. Allison’s work.

The Allison NFT is more than a simple digital document. “It’s a combination of a lab notebook and digital art,” Mr. Cohen said. A single image includes 10 pages but one can zoom in and read the documents. “I really wanted to preserve the ability to read the history in addition to viewing the beauty of the image,” he said.

The designers of the NFT also included subtle nods to the initial resistance to Dr. Allison’s ideas. The pages are all slightly tilted, because “people looked at him askew,” Mr. Cohen said. “There’s a lot of little things like that in the art.”

Dr. Lyons was reluctant to predict how much the artwork would fetch at auction. “I’d be surprised if it went for less than $100,000,” he said. “It could go into seven figures. This is a new category, and it’s hard to price anything that is a new category.”

Categories
Politics

How Do the Nobel Peace Prize Nominations Work?

Unlike major Hollywood awards ceremonies where it’s really an honor to be nominated, the Nobel Peace Prize accepts submissions from a potential pool of thousands of nominees.

The Norwegian Nobel Committee, which selects the winner, does not announce the nominees or those who nominated them until 50 years later, so that participants can report their contributions at their own discretion.

After the deadline for this year’s nominations last Sunday, Aleksei A. Navalny, the Russian dissident leader; Greta Thunberg, the youth activist for climate change; and the World Health Organization were among the nominees, Reuters reported.

Also mentioned were Stacey Abrams, the former Georgian politician who was credited with increasing voter turnout last year, and Jared Kushner, son-in-law and advisor to former President Donald J. Trump. (Mr Trump himself has been nominated for the award in at least two years of his presidency – with no two nominations faked in 2018.)

Reuters polled Norwegian lawmakers “who have been shown to have chosen the winner”.

The list of those who can submit nominations is long, including members of national governments. Officials of international peace organizations; University professors in history, social sciences, law, philosophy, theology and religion; and former recipients.

The Nobel Committee says the large number of potential nominators ensures a “wide variety of candidates,” but the group is excited about the process and has not responded to a request for clarification on the suitability of nominators.

In 1967, the last year available in the Nobel Committee Archives, 95 nominations were received (an individual or group can be nominated multiple times in the same year). The committee said there were 318 submissions last year, up from a record 376 in 2016.

There are few criteria for nominees, and the process has sometimes been exploited for naked political reasons.

As is well known, an anti-fascist legislator from Sweden nominated Adolf Hitler in 1939 in an act of satire. He “never wanted his submission to be taken seriously,” says a note on his nomination in the archive.

Joseph Stalin, the leader of the Soviet Union, was nominated twice in 1945 and 1948. Benito Mussolini, the Italian ruler, was nominated twice in 1935.

The selection process for determining a recipient is much more rigorous. The committee appointed by the Norwegian Parliament will deliberate in secret from February. The group limits submissions to a “short list” of 20 to 30 candidates prior to months of examination. The recipient will be announced in October.

The Nobel Committee has stressed that nominations are not an endorsement of the group and “must not be used to imply membership of the Nobel Peace Prize”.

But Mr Trump provides an example of how nominations themselves can be used to gain influence.

In 2019, Mr Trump announced to his supporters that he had been nominated by then Japanese Prime Minister Shinzo Abe, a claim Mr Abe would not confirm. (This year’s award went to Abiy Ahmed, Prime Minister of Ethiopia.)

Last year, after two European leaders said they had nominated Mr. Trump, White House press secretary Kayleigh McEnany called it “a hard-earned and well-deserved honor for this president.”

The 2020 award was later awarded to the World Food Program.

Mr Trump was actually nominated by two right-wing Scandinavian MPs. For his followers, however, the personal politics of the nominators or their low likelihood of receiving the award were less important than their looks.

“Every day Donald Trump is nominated for another Nobel Prize,” beamed Fox News presenter Laura Ingraham on her show. “It is obvious that Trump should receive the Nobel Prize.”

At a campaign event in October, Mr Trump complained that his nomination received less coverage than his predecessor’s. (President Barack Obama actually received the award in 2009.)

“I was just nominated for the Nobel Prize,” he said. “And then I turned on the fake news story by story. They talk about your weather on the panhandle and they talk about it. Story after story, no mention. Do you remember when Obama got it right in the beginning and didn’t even know why he got it? “

The award for Mr Obama, just nine months into his first term, was received with surprise and confusion even by the recipient.

“To be honest,” Obama said afterwards, “I don’t feel like I deserve to be with so many of the transformative personalities who have won this award, men and women who inspire and inspire me have the whole world through their courageous pursuit of peace. “